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Abstract
In a longitudinal metabolomics study, multiple metabolites are measured
from several observations at many time points. Interest lies in reducing the
dimensionality of such data and in highlighting influential metabolites which
change over time. A dynamic probabilistic principal components analysis
(DPPCA) model is proposed to achieve dimension reduction while appro-
priately modelling the correlation due to repeated measurements. This is
achieved by assuming an autoregressive model for some of the model pa-
rameters. Linear mixed models are subsequently used to identify influential
metabolites which change over time. The proposed model is used to analyse
data from a longitudinal metabolomics animal study.
1 Introduction
Metabolomics is the study of low molecular weight compounds known as metabo-
lites found in biological samples; its application reveals information on metabolic
pathways within an organism. The number of areas in which metabolomics is
applied has recently enjoyed rapid growth and metabolomics is now employed in
fields such as nutrition, toxicology and disease diagnosis. In a typical metabolomics
∗claire.gormley@ucd.ie
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study large data sets are generated using analytical technologies such as nuclear
magnetic resonance spectroscopy (NMR) (Reo, 2002) and mass spectrometry (MS)
(Dettmer et al., 2007). With respect to NMR spectroscopy the resulting spectrum
consists of a series of peaks where the height of a peak is related to the relative
abundance of the associated metabolite. Studying such metabolomic profiles gives
insight to the metabolic state of a system.
Metabolomic data sets are usually high-dimensional, in that the resulting spec-
tra contain many peaks (i.e. variables), yet they are characterised by small sam-
ple sizes – hence classical statistical approaches cannot be easily applied. The
data sets contain variables that are not independent in that metabolites can be
represented by more than one peak and metabolites can be highly correlated
(van den Berg et al., 2006). In addition to correlated variables, in longitudinal
metabolomics data sets there is further correlation structure due to the repeated
measurements of observations over time. Hence, appropriate statistical models
are required in order to appropriately model the data and extract true, important
information.
Within the metabolomics literature, principal components analysis (PCA) (Jolliffe,
2002) is often used for multivariate data exploration (Walsh et al., 2007; Smolinska et al.,
2012; Cassol et al., 2013; Carvalho et al., 2013; Bathen et al., 2013; Sachse et al.,
2012). Methods that improve and extend the application of this common statis-
tical technique will prove extremely useful to the metabolomics practitioner, and
to scientists in other fields. The application of PCA to longitudinal studies is lim-
ited however by the fact that PCA does not take into account information about
the experimental design i.e. if PCA is applied to all time points simultaneously,
measurements taken repeatedly over time are assumed independent (Choi et al.,
2006). In such a case, since PCA looks for directions in the data space with max-
imum variation, time related variation will act as a confounding factor obscuring
potential differences due to treatment.
Several extensions to PCA have been developed to take into account the ex-
perimental design of a study and therefore can be used to analyse longitudinal
metabolomics data more appropriately. These include weighted PCA (Jansen et al.,
2004) which uses weights to account for variation due to repeated measurements
and ASCA (Smilde et al., 2005) which combines analysis of variance and simulta-
neous components analysis methods to deal with complex multivariate datasets.
Jansen et al. (2009) employ local PCA models at each time point, and then link
these local models to each other. Dynamic PCA (Smilde et al., 2010) uses a back-
shift matrix to analyse data from multiple time points simultaneously. The main
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limitation of these approaches is that they do not have an associated generative
probabilistic model. Hence, it is difficult to assess the uncertainty in the fitted
model estimates, and model extensions are not feasible.
Mixed effects models have also been employed to model longitudinal metabolomics
data. Mei et al. (2009) employ a linear mixed-effects model (LMM) in the context
of feature selection for longitudinal metabolomics data, but under the assump-
tion that spectral peaks are independent variables. The high levels of correla-
tion between spectral peaks (i.e. metabolites) is biologically important however,
and such correlation structure should be explicitly modeled. In a similar vein,
Berk et al. (2011) employ smoothing splines mixed-effects models to model lon-
gitudinal metabolomics data. While these models have a statistical modelling
basis and therefore appropriately model the longitudinal aspect of the data, mul-
tiple testing issues (Dudoit et al., 2003) result as the chances of false positives
increase with the dimensionality of the data. While this problem can be con-
trolled (Benjamini and Hochberg, 1995), dimension reducing features of methods
such as PCA are attractive.
Probabilistic PCA (PPCA) is an approach to PCA based on a Gaussian latent
variable model (Tipping and Bishop, 1999; Nyamundanda et al., 2010). PPCA re-
tains the benefits of PCA, such as dimension reduction, while facilitating model
extensions through its basis in a statistical model. Here an extension of PPCA
called dynamic PPCA (DPPCA) is proposed which allows PPCA to appropriately
model the time dependencies in longitudinal metabolomics data. This is achieved
by assuming a stochastic volatility model for some of the PPCA parameters. The
proposed DPPCA model is closely related to the dynamic factor analysis model
(Aguilar and West, 2000) employed to model multivariate financial time series
data.
Data generated in longitudinal metabolomics studies form the basis for the
development of the proposed DPPCA model. Examples of such studies include,
but are not limited to, postprandial human studies and long term drug treatment
studies (Wopereis et al., 2009; Lin et al., 2011; Krug et al., 2012; Nicholson et al.,
2012). Interest lies in reducing the dimensionality of the data (for statistical
and visualisation purposes) and subsequently highlighting influential metabolites
which change over time, while appropriately modelling the longitudinal nature
of the data. The proposed DPPCA model is employed to achieve dimension re-
duction and model the time dependencies; linear mixed models (LMM) are then
employed to identify the metabolites which change over time. The utility of the
DPPCA approach is demonstrated through the analysis of data from a longitudi-
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nal metabolomics animal study.
The remainder of the article is structured as follows. An overview of longi-
tudinal metabolomics studies is presented in Section 2. The DPPCA model is
introduced in Section 3 and the use of stochastic volatility models to account for
the correlation due to repeated measurements is detailed. The DPPCA model
is estimated within the Bayesian paradigm; accordingly Section 4 specifies the
necessary prior distributions and describes the use of Markov chain Monte Carlo
(MCMC) techniques to fit the DPPCA model. Section 5 details the application
of the DPPCA model to a longitudinal metabolomics data set. Discussion of the
developed model and further avenues of research are deferred until the conclusion,
in Section 6.
2 Longitudinal metabolomics studies
In recent years, a number of longitudinal metabolomics datasets have emerged
in the literature (Wopereis et al., 2009; Lin et al., 2011; Krug et al., 2012). With
regard to human applications, a number of studies employing metabolomics over
time following acute challenges such as the oral glucose tolerance test have recently
been published and shown to be extremely powerful in studying subtle changes.
Applying metabolomics to longitudinal animal studies for determining long term
drug toxicity and efficacy is also an important emergent area. In such applications
a number of key study aims typically exist which, in general, can be described as
follows:
(i) data visualisation
(ii) assessing the effect of time within each treatment group and
(iii) identifying metabolites which change over time within each treatment group.
The DPPCA model proposed here helps address these specific aims. In the
case of (i) the DPPCA model facilitates visualisation of the study participants in
a reduced dimensional space, while appropriately modelling the time course nature
of the data. The effect of time within each treatment group (aim (ii)) can be as-
sessed by applying the DPPCA model to the data from each treatment group. An
additional output of the DPPCA model is a list of the most influential metabolites
within each group. To address aim (iii) univariate analyses with LMM are then
carried out to identify those influential metabolites which change over time.
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Metabolomics data from a longitudinal animal study motivate and illustrate the
proposed DPPCA model. The study has been described in detail in Carmody and Brennan
(2010). Briefly, an animal model of epilepsy was employed by repeated adminis-
tration of pentylenetetrazole (PTZ) which leads to the development of generalised
tonic-clonic seizures. Over the administration period (5 weeks) urine samples were
collected from treated animals (PTZ treated) and control animals (saline treated
animals). The aim of the study was to determine metabolic changes that occur
over time during PTZ treatment.
NMR spectra were acquired from the urine samples and the spectra were inte-
grated into bin regions of 0.04 parts per million (ppm), excluding the water regions
(4.0–6.0 ppm). For the purposes of this work, the final acquired data set consists
of NMR spectra for n = 15 animals (8 treated and 7 control), each containing
p = 189 spectral bin regions, from M = 8 time points. The p = 189 peaks in
the spectra at different chemical shift values (measured in ppm) relate to specific
metabolites; the height of a peak in any spectrum details the relative abundance
of the associated metabolite in the animal’s urine sample. Figure 1 illustrates a
metabolomic spectrum resulting from the urine sample collected at a single time
point from an animal in the study.
3 Dynamic Probabilistic Principal Components
Analysis
Probabilistic principal components analysis (PPCA) is a latent factor model con-
strained such that the maximum likelihood estimates of the parameters span the
principal subspace of conventional PCA. Given its underlying assumptions how-
ever, PPCA is only applicable to data from a cross sectional study. Here an
extension of PPCA to a dynamic PPCA (DPPCA) model is developed; a brief
introduction to PPCA, and its extension to the DPPCA model, are detailed in
what follows.
3.1 Probabilistic Principal Components Analysis (PPCA)
PPCA is a generative statistical model which models a high-dimensional observed
data point as a linear function of a corresponding low-dimensional latent variable
plus isotropic (full-dimensional) noise. For each of n animals, let xTi = (xi1, . . . , xip)
denote the set of p observed variables for animal i (eg. an NMR spectrum with p
spectral bins). The PPCA model relates each xi to a q-dimensional latent Gaussian
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Figure 1: A metabolomic profile resulting from the urine sample collected at a
single time point from an animal in the longitudinal metabolomic study.
variable ui (typically q ≪ p) through the linear model:
xi =Wui + ǫi
where W is a p × q loadings matrix and the error term ǫi is assumed to have a
multivariate Gaussian distribution, centred at zero with covariance σ2I, where I
denotes the identity matrix. The error term models the part of the observed data
which cannot be accounted for by the q underlying latent variables, or principle
components (PCs). Assuming a standard multivariate normal (MVN) distribution
for ui, each data point has a zero mean multivariate normal distribution with
covariance WWT + σ2I.
Crucially, the likelihood of the PPCA model is maximized when the columns of
W span the principal subspace of conventional PCA (Tipping and Bishop, 1999).
Thus the maximum likelihood estimate of the loadings matrix in PPCA corre-
sponds exactly to the loadings matrix in conventional PCA. Hence the model
output in PPCA is exactly that obtained in conventional PCA, but with the ad-
ditional advantages of uncertainty assessment and potential model extensions.
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3.2 Dynamic Probabilistic Principal Components Analysis
(DPPCA)
The derivation of PCA from a probabilistic framework facilitates the development
of dynamic PPCA as a tool for modelling longitudinal multivariate data. Under
the DPPCA model, the set of p observed variables xim for animal i at time point
m (m = 1, . . . ,M) is modeled as:
xim = Wmuim + ǫim (1)
where Wm, the loadings, and u
T
im = (ui1m, . . . , uiqm), the latent scores, vary with
time.
Unlike the PPCA model which constrains the covariance of the multivariate
Gaussian distribution of the latent variables to be an identity matrix, the DPPCA
model eases the equal variance restriction such that
p(uim) = MVNq(0,Hm)
where Hm = diag(h1m, . . . , hqm). This assumption allows the variances of the un-
derlying latent variables to differ across the latent dimensions and to depend on
time.
The error, ǫim, for animal i at time m is also assumed to have a multivariate
Gaussian distribution:
p(ǫim) = MVNp(0, σ
2
mI).
Again, the variance parameter σ2m varies with time. The errors, ǫim and the la-
tent variables (or scores), uim are assumed to be mutually independent for all
m = 1, . . . ,M .
While the variance parameter of the error terms σ2m varies with time, it is
constrained to be constant across all observed variables. This is in line with the
assumptions of the underlying PPCA model; should the variances be unconstrained
across variables a dynamic factor analytic model results (McNicholas and Murphy,
2008; Aguilar and West, 2000). Thus the DPPCA model can be viewed as a con-
strained dynamic factor model.
The choice of developing the DPPCA model, rather than employing an alterna-
tive dynamic factor model to analyse the metabolomic data under study, deserves
explanation. The manner in which time dependence is accounted for in the DP-
PCA model, and the constraints employed, are motivated by the explicit needs
of the motivating metabolomics application. The metabolomics practitioners are
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interested in time evolving metabolites, hence the need for a different loadings
matrix at each time point, leading to a highly parameterised model. Further,
strongly motivated by the ubiquitous use, understanding and acceptance of PCA in
the metabolomics field (Smolinska et al., 2012; Cassol et al., 2013; Carvalho et al.,
2013; Bathen et al., 2013; Sachse et al., 2012), maintaining a link to PPCA was
deemed to be highly desirable. As the link to PPCA occurs by constraining the
error variances to be equal, this modelling decision satisfied the metabolomic sci-
entists, and provided a more parsimonious model than a generic dynamic factor
model. The appropriateness of the DPPCA model assumptions are assessed after
model fitting in Section 5.4, using posterior predictive model checking.
3.3 Stochastic Volatility Models
Stochastic volatility models (Jacquier et al., 1994; Kim et al., 1998) are popular in
econometrics and finance where they are typically employed to model the variance
of returns over time, which are highly correlated. The DPPCA model accounts for
the correlation due to repeated measurements through the use of stochastic volatil-
ity (SV) models. Specifically, the DPPCA model assumes that at time point m the
variances h1m, . . . , hqm of the latent variables and the error variances σ
2
m follow a
latent stochastic process. These assumptions allow the DPPCA model to account
for any potential time dependence in longitudinal multivariate data.
Again, the motivation behind the incorporation of SV models in DPPCA re-
quires explanation. While SV models typically model settings with many time
points (Aguilar and West, 2000), they have been employed when modelling longi-
tudinal multivariate data, where the number of time points is low. Ramoni et al.
(2002), Fang-Xiang et al. (2005) and Wang et al. (2008), for example, employ SV
models for modelling high dimensional time course data where the number of time
points ranges from 8 to 18. Hence the SV model was deemed suitable to model the
evolution of the latent variables over time. The appropriateness of the SV model
assumptions is assessed after model fitting in Section 5.4.
3.3.1 A stochastic volatility model for the latent variables
An SV model on the latent variable uijm of animal i (i = 1, . . . , n) for principal
component j (j = 1, . . . , q) at time point m (m = 1, . . . ,M) can be expressed as:
uijm = exp(λjm/2)ζijm
where λjm = log(hjm) is known as the log volatility and ζijm, which has a standard
univariate Gaussian distribution, denotes the error term of the SV model. Thus the
conditional distribution of the latent variable is uijm|λjm ∼ N [0, exp(λjm)]. The
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q-vector of log volatilities, λTm = (λ1m, . . . , λqm), is assumed to have a stationary
first order vector autoregressive process VAR(1) centered around a mean µT =
(µ1, . . . , µq):
λm = µ+ Φ(λm−1 − µ) +Rm
where Φ is a matrix of persistence parameters and Rm ∼ MVNq(0,V ) are in-
dependent innovations. The model restricts dependencies across the principal
dimensions by constraining the matrix of persistence parameters Φ and the co-
variance of the innovations V to be diagonal i.e. Φ = diag(φ1 , . . . , φq) and
V = diag(v 21 , . . . , v
2
q ) respectively. The innovation variance v
2
j is the uncertainty
associated with predicting the current log volatility using the log volatility from
the previous time point on component j. The persistence parameter Φ is the
parameter of interest; it measures the strength of the relationship between time
points. For stationarity, the persistence parameter φj is constrained to lie be-
tween -1 and 1 (Kim et al., 1998). The initial state, by stationarity, is drawn from
the model p(λ1) = MVNq[µ, diag(
v2
1
1−φ2
1
, . . . ,
v2
q
1−φ2
q
)]. The distribution of the log
volatilities λm given the log volatilities of the previous time point λm−1 is given
by MVNq[µ+ Φ(λm−1 − µ),V ] for m > 1.
Constraining the covariance matrix V to be diagonal is a modelling decision
motivated by the fact that the PPCA model does not facilitate dependence across
the principal components and PPCA underpins the DPPCA model, as detailed
in Section 3.2. Such a model was considered by Harvey et al. (1994), Kim et al.
(1998) and Jacquier et al. (1995) among others; Aguilar and West (2000) allow
correlation across dimensions, motivated by their financial application area.
3.3.2 A stochastic volatility model for the errors
Additionally, another SV model is adopted to model the potential time dependence
in the errors of the DPPCA model. The p-vector of errors of observation i at time
m can be expressed as ǫim = exp[ηm/2]ξim where ηm = log(σ
2
m) is the log volatility
at timem and ξim ∼MV Np(0, I). The log volatilities ηm on the errors are assumed
to have a stationary first order autoregressive process AR(1):
ηm = ν + φ(ηm−1 − ν) + rm
where the center of the AR(1) model is ν and the persistence parameter φ is
constrained such that φ ∈ [−1, 1]. The innovations of the AR(1) model are assumed
to be normally distributed, rm ∼ N(0, v
2). It follows that the initial state of the
SV model is p(η1) = N(ν,
v2
1−φ2
) and that p(ηm|ηm−1) = N [ν + φ(ηm−1 − ν), v
2] for
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m > 1. Note that, as stated in Section 3.2, to maintain the link to PPCA and for
reasons of parsimony, each of the p dimensions in the error ǫim are constrained to
follow the same AR(1) model.
4 Estimation of the DPPCA model
Under the DPPCA model, the full augmented data likelihood function based on the
data X = (X1, . . . ,Xn) and the latent variables U = (U1, . . .Un), Λ = (λ1 , . . . ,λM )
is:
p(X,U,Λ,η|W, θ1 , θ2 ) =
[
M∏
m=1
n∏
i=1
p(xim|Wm,uim, ηm)p(uim|λm)
]
p(η|θ1)p(Λ|θ2 )
where θ1 = (ν, φ, v
2) and θ2 = (µ,Φ,V ) denote the SV model parameters on
the errors and latent scores respectively. The PPCA model on each time point
p(xim|Wm,uim, ηm) is MVNp[Wuim, exp(ηm)I].
A Bayesian approach is taken when estimating the DPPCA model; this re-
quires the specification of prior distributions for all the model parameters. The
resulting posterior distribution is intricate and Markov chain Monte Carlo meth-
ods are necessary to produce realizations of the model parameters. Specifically, a
Metropolis-within-Gibbs algorithm is required to sample from the full conditional
distributions for all model parameters and latent variables.
4.1 Prior distributions
Prior distributions over the full set of the model parameters need to be specified.
It is assumed that the prior distributions on the model parameters are indepen-
dent. Under the PPCA part of the DPPCA model, the only parameters are the
loadings matrices W1, . . . ,WM . A q-dimensional multivariate normal prior distri-
bution, centered at 0 with covariance Ωm , is assumed for each row of the loadings
matrix Wm at time m.
The remaining model parameters are all parameters of the SV part of the
DPPCA model. Non-informative normal prior distributions are specified on the
means of the SV models i.e. a N(µν , σ
2
ν) distribution is specified for ν and a
N(µµ, σ
2
µ) distribution is assumed on each of the univariate elements of µ, where
the variance hyperparameter in each of these priors is large. A conjugate prior
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is assumed for the variances of the innovations in the SV models i.e. an inverse
gamma IG(α/2, β/2) distribution is chosen for the prior distribution of v2 and for
each of the diagonal elements of V . For stationarity, the persistence parameters
of the SV models are constrained to lie in [−1, 1]; accordingly the prior distribu-
tions on φ and on the diagonal elements of Φ are truncated normal distributions,
N[−1,1](µφ, σ
2
φ).
As in any Bayesian setting, the choice of prior distribution can potentially
influence parameter inference. Sensitivity analyses were conducted to assess the
influence of different choices of priors on the resulting posterior distribution. Some
sensitivity was observed in the case of the persistence parameters. Kim et al.
(1998) employ a transformed beta prior for the persistence parameters, but sen-
sitivity analyses here suggested that the posterior distribution strongly depended
on the values of the hyperparameters used. In a similar setting to the DPPCA
model, Aguilar and West (2000) employ a truncated (between ±1) Gaussian prior
for the persistence parameters; the posterior distributions were less sensitive to
the parameter specification under this prior. Thus, a Gaussian prior, truncated
(between ±1), was employed here for the persistence parameters.
4.2 The Metropolis-within-Gibbs sampler
Given the specified prior distributions, the resulting posterior distribution is intri-
cate and Markov chain Monte Carlo (MCMC) methods are required to produce re-
alizations of the model parameters. The full conditional distributions for the load-
ings matrices Wm, the latent scores Um, the SV model means ν and µ, and the SV
model innovation variances v2 and V exist in standard form, and a straightforward
Gibbs sampler can be employed to draw samples. However, the full conditional
distributions for the persistence parameters φ and Φ and for the log volatilities Λ
and η are not available in closed form; values from these distributions are there-
fore sampled using a Metropolis Hastings step. Hence a Metropolis-within-Gibbs
algorithm (Gilks et al., 1996) is required to sample from the full conditional dis-
tributions for all model parameters and latent variables. Carlin and Louis (2000)
detail the conditions necessary for the convergence of such a hybrid algorithm.
Detailed derivations of the full conditional distributions for the DPPCA model
parameters and latent variables are given in the Supplementary Material. For
the Metropolis-Hastings steps to update the log volatilities, proposal distributions
which are closely related to the shape and orientation of the target full conditional
distributions provide an improved rate of convergence. To achieve this, second
order Taylor expansions of the full conditional distributions for η and Λ are em-
ployed to guide the choice of an effective proposal distribution and its parameter
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values (Kim et al., 1998). A summary of one sweep of the Metropolis-within-Gibbs
sampler for the DPPCA model is given in the Supplementary Material.
4.3 Model Identification
As with factor analytic models, the DPPCA model suffers from identification is-
sues. Subjecting the loadings matrix and latent scores to an orthogonal rotation
gives rise to the same distribution for the observed data. Thus it is not possible
to identify the model parameters from the observed data unless restrictions are
imposed.
Many attempts to deal with non-identifiability of the related factor analytic
models are detailed in the literature. Most commonly, a unique model is de-
fined by constraining the loadings matrix such that the first q rows are lower-
triangular with positive diagonal elements (Geweke and Zhou, 1996). However
imposing this structure also imposes structure on the ordering of the variables
(Aguilar and West, 2000). Within the context of the motivating metabolomics
application, such a structure cannot be imposed on the variables as the ordering
of the spectral peaks within a metabolomics spectrum is important.
The approach taken here is to estimate a fully unconstrained loadings matrix
using the Metropolis-within-Gibbs sampler detailed in the Supplementary Ma-
terial. Procrustean techniques (Borg and Groenen, 2005) are then employed to
post-process the sampled loadings matrices to match them to the maximum likeli-
hood estimate (MLE) of the loadings matrix resulting from fitting a PPCA model
to data from the relevant time point. The MLE is used only as a template, to
identify the model. The transformation required to match the loadings matrices
is also applied to the latent scores. In practice, this has proved to be a fast and
satisfactory approach to dealing with model non-identifiability.
5 Results
As detailed in Section 2, three specific issues associated with the longitudinal
metabolomics study need to be addressed: (i) data visualisation, (ii) assessing the
effect of time within each treatment group and (iii) identifying the specific metabo-
lites which change over time within each treatment group. The DPPCA model, in
combination with linear mixed models, is fitted to the longitudinal metabolomics
data set to address these issues. For reasons of visual clarity, only models with
q = 2 were considered. For each set of results detailed below, the prior distributions
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employed for the DPPCA model parameters were specifically:
wkm ∼ MVNq(0, I) for k = 1, . . . , p and m = 1, . . . ,M.
ν ∼ N(0, 10)
v2 ∼ IG(6/2, 0.5/2)
φ ∼ N[−1,1](0.75, 0.1)
The priors on the univariate entries of the set of parameters θ2 = (µ,Φ,V ) were
the same as those for θ1 = (ν, φ, v
2). The Metropolis-within-Gibbs sampler was
run for 500,000 iterations, thinned every 500th iteration. The first 5,000 iterations
were discarded as burn-in. The MCMC algorithm was initialized using estimates
of the loading matrices from fitting a PPCA model to data from each time point
independently; stochastic volatility model parameters were set equal to their prior
means. Trace plots and autocorrelation function (ACF) plots for the MCMC
samples of the parameters were used to assess convergence of the algorithm.
5.1 Data Visualisation: Exploring Metabolomic Trajecto-
ries
In longitudinal metabolomics studies, trajectories through the latent principal sub-
space can be used to gain visual insight to the response of animals during the study
period. Examining the location, magnitude and direction of these metabolomic
trajectories provides visual insight to the metabolomic changes over time.
Here metabolomic trajectories were estimated using the latent scores of ani-
mals resulting from collectively modelling data from both treatment groups using
a DPPCA model. Such a model takes into account the covariation between the
metabolites and any correlation across time; this facilitates visualisation of animals
in a reduced dimensional space, while appropriately modelling the time course na-
ture of the data. Trace plots for the estimated latent scores and loadings are given
in the Supplementary Material.
The metabolomic trajectories of four randomly sampled animals are illustrated
in Figure 2. Under the DPPCA model, each time point m has a different princi-
pal subspace, defined by the columns of the relevant loadings matrix Wm. Hence
the latent scores of animals at different time points lie in different subspaces. To
visualise the metabolomic trajectories the latent scores must therefore be unified.
This is achieved by again drawing on Procrustean ideas, where the loadings ma-
trix from the first time point is used as the reference matrix. The loadings matrix
from each subsequent time point m is rotated to best match the loadings matrix
from the first time point; the same rotation is then applied to the associated set
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of scores from time point m. This facilitates illustration of the movement of the
latent scores over time within the same principal subspace. Figure 2 therefore
provides visual insight to the animals’ metabolomic trajectories in the principal
subspace from the first time point.
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Figure 2: Individual trajectories for four randomly sampled animals, in the prin-
cipal subspace from the first time point. (a) An animal from the control group
(black solid lines) and an animal from the treated group (red dashed lines) and
(b) an animal from the control group (black solid lines) and an animal from the
treated group (red dashed lines). The digits represent the time points of the study
and arrows illustrate movement through time.
Figure 2 suggests the presence of a treatment effect through the visible separa-
tion of the locations of the treated and control animals in the principal subspace
from the first time point. The difference in the biochemical composition of the
urine due to treatment is highlighted by the different ‘metabolic starting posi-
tions’ of the trajectories for the randomly selected animals from the control group
and those from the treatment groups. This is due to the fact that the urine sam-
ples analysed at time point 1 actually resulted from day 3 of the study, at which
stage the treatment is apparently having an effect.
The trajectories also demonstrate that the magnitude of the metabolic changes
in the biochemical composition of the urine samples is much greater in the treat-
ment group than in the control group, over time. This is evidenced by the larger
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movements between time points by the treated animals. This shows that the vari-
ability in the urinary composition of the treated animals over time is greater than
that in the control group. Thus, the metabolomic trajectories provide a visual
insight to the metabolomic changes occurring over time.
5.2 Exploring the Effect of Time
The second aim of the longitudinal study was to ascertain if there is a time effect
within each treatment group. In an effort to quantify the effect of time, the
DPPCA model was fitted separately to each treatment group. If a time effect is
established, the task will then be to identify metabolites whose concentration level
is significantly changing over time.
5.2.1 Exploring the Effect of Time in the Treatment Group
The DPPCA model was fitted to the metabolomic spectra from the animals in
the treatment group. The persistence parameters in the SV models are the pa-
rameters of interest as they quantify the strength of the relationship between the
time points. Figure 3(a) illustrates the posterior distribution of the persistence
parameter (φ) of the SV model on the errors. The relevant trace and ACF plots
are given in Figure 3(b) and Figure 3(c) respectively. The posterior mean of φ
was large and positive (φˆ = 0.69) and significant (95% quantile based credible
interval (CI) (0.15, 0.97)). The persistence parameters of the SV model on the
latent variables for PC 1 and PC 2 were also estimated to be large and significant
at φˆ1 = 0.64 (0.07, 0.97) and φˆ2 = 0.66 (0.08, 0.97), respectively. The posterior
means suggest that a positive time dependency exists among the spectra from the
treatment group.
Given that a time effect has been established, the third aim of the study was
to identify the specific metabolites which change over time within the treatment
group. This is achieved by first using the DPPCA model to expose those metabo-
lites which influence the data structure at each time point. Under the DPPCA
model, this translates to identifying a subset of metabolites whose posterior mean
loadings are largest (in terms of magnitude) at each time point. Standard lin-
ear mixed models are then fitted to these ‘influential metabolites’ to identify
those which change over time. This approach yields a panel of metabolites which
evolve over time, while appropriately accounting for the covariation in the high-
dimensional data, and the time related dependencies.
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Figure 3: The persistence parameter, φ, of the SV model on the error variances in
the treatment group: (a) plot of the posterior density, (b) trace plot and (c) ACF
plot. The horizontal line in (b) illustrates the posterior mean of φ.
After fitting the DPPCA model to the spectra from animals in the treatment
group, several spectral regions (corresponding to metabolites) were identified as
influencing the underlying structure of the data. At each time point, the absolute
values of the posterior mean loadings on PC1 were ranked in descending order.
The top five influential spectral bins at each time point were determined and are
shown in Figure 4. None of the 95% CIs associated with these spectral bins in-
cluded zero. The set of the top five spectral bins across all M = 8 time points
consists of only eight unique spectral bins (2.46ppm, 2.54ppm, 2.58ppm, 2.66ppm,
2.7ppm, 2.74ppm, 3.02ppm and 3.26ppm).
Bayesian linear mixed models were fitted to the data associated with the eight
unique influential spectral bins to determine which, if any, have concentrations
which evolve over time. A random intercept model with cubic time effect was the
most complex model considered; no interaction terms were considered. A back-
wards selection type approach was taken to model selection for each spectral bin
considered. Of the eight spectral bins considered, six were deemed to have signifi-
cantly fluctuating concentration levels over time. Figure 5 illustrates the predicted
average intensity levels for each of the six spectral bins.
The metabolites identified to be evolving over time include the metabolite
2-oxoglutarate, represented by the spectral bins 2.46ppm and 3.02ppm. The con-
centration level of 2-oxoglutarate decreases initially during the study and increases
at later time points, as illustrated by the similar behaviour of the predicted in-
tensities of 2.46ppm and 3.02ppm in Figure 5. The model also predicts a linear
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Figure 4: Barplots of the posterior mean loadings for the top five influential spec-
tral bins, which correspond to metabolites, in the treatment group. The error bars
are the corresponding 95% quantile based credible intervals.
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Figure 5: The LMM predicted average intensities of the six influential spectral
bins which evolve over time in the treatment group.
decreasing metabolic time profile for spectral bin 2.7ppm. Spectral bin 2.54ppm
has a positive quadratic time effect in the treated animals i.e. the concentration
level decreases and then increases over time. Spectral bins 2.58ppm and 3.26ppm
have a positive linear time trend. Individual animal and predicted profiles for
three of the six evolving spectral bins are given in the Supplementary Material.
5.2.2 Exploring the Effect of Time in the Control Group
To establish the presence or absence of a time effect in the control group of animals,
and to subsequently highlight those metabolites which evolve over time, the same
approach as that taken in Section 5.2.1 was followed. That is, the DPPCA model
was fitted to the spectra of animals in the control group only; Table 1 details the
posterior means of the persistence parameters of the SV model on the errors and
on the latent variables, with their corresponding 95% CIs. Table 1 shows that the
persistence parameters of the SV models are large and significant, suggesting that
there is a relationship across time.
Given that a time effect has been established in the control group, interest then
lies in highlighting those metabolites which evolve over time. The posterior mean
PC1 loadings of the DPPCA model were ranked to select the top five influential
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Table 1: Posterior means of the persistence parameters and the corresponding 95%
CIs for the control group.
SV model Estimate (95% CI)
Errors (φ) 0.66 (0.09,0.98)
PC 1 (φ1) 0.65 (0.10,0.98)
PC 2 (φ2) 0.66 (0.07,0.97)
spectral bins at each time point; again, none of the associated 95% CIs included
zero. From this list of spectral bins, those which evolve over time in the control
group were identified. Seven unique influential spectral bins were ranked in the
top five over the eight time points; Bayesian LMM models were fitted to the pro-
files for each of these and all seven were identified as evolving over time. Figure 6
illustrates the predicted average intensity levels over the eight time points, under
the selected LMM for each of the seven evolving spectral bins.
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Figure 6: The LMM predicted average intensities of the seven influential spectral
bins which evolve over time in the control group.
The metabolite 2-oxoglutarate (with corresponding spectral bins 2.46ppm and
3.02ppm) was predicted by the Bayesian LMM to have a negative quadratic time
effect in the control group i.e. its concentration increases and then decreases over
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time (see Figure 6). Spectral bins 2.54ppm and 3.42ppm have positive quadratic
time effects. The remaining evolving spectral bins (2.58ppm, 2.7ppm and 3.26ppm)
have cubic time effects. Individual animal and predicted profiles for three of the
seven evolving spectral bins are given in the Supplementary Material.
5.3 Comparing evolving metabolites in the two treatment
groups
As the aim of the longitudinal metabolomics study was to determine metabolic
changes that occur over time during PTZ treatment, of interest are the similarities
and differences between the set of evolving metabolites in the treatment group and
the set in the control group.
A total of six spectral bins were highlighted as evolving in the treatment group
and seven in the control group. There is considerable overlap between the two sets
of evolving bins, with 3.42ppm evolving in the control group only. While some
of the common spectral bins had the same evolution pattern, some differed. In
particular, the spectral bins 2.46ppm and 3.02ppm relating to the 2-oxoglutarate
metabolite were predicted to have opposite quadratic effects in the treatment group
and in the control group. Figure 7, which shows the predicted average intensities
for these two spectral bins only in both treatment groups, clearly illustrates this
phenomenon. The biological basis of the diverse response of this metabolite will
be investigated in future metabolomic experiments.
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Figure 7: The LMM predicted average intensities of the two spectral bins 2.46ppm
and 3.02ppm which relate to the metabolite 2-oxoglutarate in (a) the treatment
group and (b) the control group.
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5.4 Assessing model fit
As with any applied statistical analysis, the modelling assumptions employed need
to be assessed to ensure valid inference. In the case of the DPPCA model, the
modelling assumptions are the multivariate Gaussian distribution for the latent
variables and the error terms, and the stochastic volatility model assumed to con-
trol the evolution of the latent variables over time. Posterior predictive model
checking (Gelman et al., 2003) was employed to assess these modelling assump-
tions. Replicated data were simulated from the posterior predictive distribution
and compared to the observed data from each treatment group. Given the mul-
tivariate nature of the data, the replicated and observed data were compared by
examining the mean absolute deviations (MADs) between the covariance matrix
of the observed data and the covariance matrix of the replicated data at each
time point (Ansari et al. (2002)). The resulting MADs suggested that the DP-
PCA model fits well since the vast majority of the deviations were close to zero.
A histogram of the MADs is available in the Supplementary Material. There were
some large MADs (6% of MADs were > 1 for the treatment group data and 4%
for the control group data) but given the large number of covariance parameters
being compared, this was not viewed as sufficient evidence of invalid assumptions
and poor model fit. The few large MADs may arise due to the fact that the num-
ber of latent dimensions was fixed at 2 (for visual substantive reasons), and that
some parameters were constrained (for reasons of parsimony). Fitting a higher
dimensional and less parsimonious model to the time course metabolomic data is
an area of further research.
6 Discussion
analysing longitudinal data from metabolomics studies is problematic due to the
dimensionality of the data, the correlated metabolites and correlation structure
due to repeated measurements over time. Many currently existing approaches to
analysing such data sets either have the limitation of confounding treatment vari-
ation with variability due to the longitudinal nature of the data or they ignore the
fact that metabolites do not work independently of each other. Here the DPPCA
methodology has been proposed which combines probabilistic PCA and stochastic
volatility models to disentangle the two types of variation in the data, while also
accounting for its high-dimensionality.
The DPPCA model successfully addressed the aims of the metabolomic study
i.e. visualising the metabolomic trajectories through time, quantifying the effect of
time, and highlighting metabolites which evolve over time. Importantly, the DP-
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PCA model highlighted the contrasting behaviour of the 2-oxoglutarate metabolite
between the two treatment groups under study. Future work will examine further
this contrasting behaviour.
Many areas of further research naturally arise from the DPPCA model. From
a practical viewpoint, fitting the DPPCA model is computationally expensive,
mostly due to the costly sampling of the log volatilities. Several approaches to sam-
pling log volatilities for SV models are suggested and reviewed by Jacquier et al.
(1994); Kim et al. (1998) and Platanioti et al. (2005). Further work in this area
would expedite the convergence of the MCMC chain. Also, while data from 16
times points were collected, only 8 time points were analysed here, due to missing
data. Imputation of such data would potentially be feasible within the model fit-
ting algorithm.
Motivated by the real application area, only principal subspaces of dimension
2 were considered here; clearly the choice of dimensionality can be viewed as a
model selection issue and any of the myriad of approaches to model selection in
the Bayesian paradigm by evaluating the marginal likelihood could be employed;
Friel and Wyse (2012) provide a review of such approaches. However, it is antici-
pated that such approaches would be computationally expensive in the setting of
the DPPCA model. Minka (2000) proposes a computationally efficient approach
to selecting the optimal dimensionality in PCA, which might also provide a possi-
ble solution to the model selection problem here.
In terms of the DPPCA model itself, the manner in which the dynamics are
modelled in the DPPCA model raises further research questions. Alternative ap-
proaches to modelling the time dynamics should be examined, for example (as
suggested by a referee) using state-space models for the loadings matrix. Fur-
ther, research into a random effects PPCA model to model such longitudinal
metabolomics data is underway (Nyamundanda et al., 2013). The DPPCA ap-
proach proposed here can be thought of as an approach to identifying the subset
of influential variables, which are then analysed via LMMs to highlight those which
are time evolving. Hence, the issue of multiple testing is reduced but not eradi-
cated under the DPPCA model; this could be addressed by employing a hierar-
chical modelling framework (Gelman et al., 2003). Further, the proposed DPPCA
approach to highlighting time evolving metabolites requires a two step process:
fitting a DPPCA model, followed by fitting LMMs. A more elegant approach
would combine the ideas underlying both models into a single model. Clearly the
development of the DPPCA model gives rise to many and varied areas of future
work.
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